glp 1 agonist retatrutide PDB-101: Molecule of the Month: GLP-1 Receptor Agonists Retatrutide for Lab-Grade Canadian Researchers
Description
Around the same time, companies like Novo Nordisk began medicinal chemistry efforts to create modified human GLP-1 analogues with longer half-lives (for example, by adding fatty acid chains to help the peptide bind to albumin and resist degradation) ( [47] ) ( [48] )

Figure S7
01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)
Pharmacopsychiatry , 55(4), 167-177
Insurance coverage for anti-obesity medications varies [58], leading to inconsistent access across different populations